Rightway

“Thrive's portfolio also targets access to existing breakthroughs”

“Rightway works on pharmacy benefits and access to novel drugs.”

“Raises $155M Series E Round from Khosla Ventures, Francisco Partners”

“valued at $1.75 billion and is exploring an IPO in the next few years, Bloomberg reported.”